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Multiple Sulfatase Deficiency Is Caused by
Mutations in the Gene Encoding the Human
C-Formylglycine Generating Enzyme
thyosis, and chondrodysplasia punctata (Hopwood and
Ballabio, 2001).
Mammalian cells synthesize sulfatases at ribosomes
bound to the endoplasmic reticulum. During or shortly
after protein translocation and while the sulfatase poly-
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Universita¨t Go¨ttingen peptides are still largely unfolded, FGly residues are
generated (Dierks et al., 1997, 1998a) by lumenal compo-Heinrich-Du¨ker-Weg 12
37073 Go¨ttingen nents of the endoplasmic reticulum (Fey et al., 2001). A
linear sequence motif following the cysteine residue toGermany
be modified (CXPSRXXX[L/M]TG[R/K/L]) posttransla-
tionally directs the FGly generation in sulfatases (Dierks
et al., 1999). This FGly modification motif is locatedSummary
50–80 residues downstream of the signal peptidase
cleavage site. A 16-mer sequence of arylsulfatase AC-formylglycine (FGly) is the catalytic residue in the
active site of eukaryotic sulfatases. It is posttransla- (ASA) encompassing this motif was shown to be suffi-
cient to direct FGly formation when inserted into a heter-tionally generated from a cysteine in the endoplasmic
reticulum. The genetic defect of FGly formation causes ologous polypeptide background (Dierks et al., 1999).
Using ribosome-associated nascent ASA fragments asmultiple sulfatase deficiency (MSD), a lysosomal stor-
age disorder. We purified the FGly generating enzyme substrate and the soluble content of the endoplasmic
reticulum as enzyme source FGly formation could be(FGE) and identified its gene and nine mutations in
seven MSD patients. In patient fibroblasts, the activity demonstrated in an in vitro system (Fey et al., 2001).
In the present study we have purified the FGly generat-of sulfatases is partially restored by transduction of
FGE encoding cDNA, but not by cDNA carrying an MSD ing enzyme (FGE) from bovine testis to homogeneity,
identified its molecular nature, and characterized muta-mutation. The gene encoding FGE is highly conserved
among pro- and eukaryotes and has a paralog of un- tions in patients with multiple sulfatase deficiency.
known function in vertebrates. FGE is localized in the
endoplasmic reticulum and is predicted to have a tri- Results
partite domain structure.
A Rapid Peptide-Based Assay for FGE Activity
Introduction We had developed an assay for determining FGE activity
in microsome extracts using in vitro synthesized
Sulfatases in eukaryotes and prokaryotes contain a [35S]ASA fragments as substrate. The fragments were
unique amino acid derivative, C-formylglycine (FGly), added to the assay mixture as ribosome-associated na-
which is posttranslationally generated from cysteine scent chain complexes. The quantitation of the product
(eukaryotes and prokaryotes) or serine (prokaryotes) included tryptic digestion, separation of the peptides
(Schmidt et al., 1995; Selmer et al., 1996; Miech et al., by RP-HPLC, and identification and quantitation of the
1998; Dierks et al., 1998a, 1997, 1998b; Szameit et al., 35S-labeled FGly containing tryptic peptide by a combi-
1999). FGly is essential for catalytic activity of sulfatases. nation of chemical derivatization to hydrazones, RP-
It is present in the active site as an aldehyde hydrate HPLC separation, and liquid scintillation counting (Fey
(Boltes et al., 2001). During catalysis, one of its geminal et al., 2001). For monitoring the enzyme activity during
hydroxyl groups performs a nucleophilic attack on the purification, this cumbersome procedure needed to be
sulfur of the sulfate group of the substrate and becomes modified. A new assay based on a peptidic substrate
covalently sulfated in the enzyme intermediate. The and matrix-assisted laser desorption/ionisation time-of-
other hydroxyl group is required for an elimination reac- flight (MALDI-TOF) mass spectrometry was developed.
tion by which the sulfated enzyme intermediate is desul- A synthetic 16-mer peptide corresponding to ASA res-
fated and the FGly regenerated (Lukatela et al., 1998; idues 65–80 and containing the sequence motif required
von Bu¨low et al., 2001). for FGly formation inhibited the FGE activity in the in
The key role of the FGly residue for the biological vitro assay (Fey et al., 2001). This suggested that pep-
function of sulfatases is illustrated by multiple sulfatase tides such as ASA65–80 may serve as substrates for
deficiency (MSD), a rare autosomal recessive disorder FGE. We synthesized the 23-mer peptide P23, which
in man. In MSD, the activity of all sulfatases is severely corresponds to ASA residues 60–80, with an additional
decreased due to the inability to generate the FGly resi- N-acetylated methionine and a C-amidated serine resi-
dues (Schmidt et al., 1995). The phenotype of MSD com- due to protect its N- and C terminus, respectively. The
bines the clinical features of disorders caused by the cysteine and the FGly containing form of P23 could be
deficiency of single sulfatases, such as metachromatic identified and quantified by MALDI-TOF mass spec-
leukodystrophy, mucopolysaccharidoses, X-linked ich- trometry. The presence of the FGly residue in position
11 of P23 was verified by MALDI-TOF post source decay
mass spectrometry (see Peng et al., 2003). Incubation*Correspondence: kfigura@gwdg.de
1These authors contributed equally to this work. of P23 with extracts from microsomes of bovine pan-
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Figure 2. Purification of FGE from Bovine Testis
Aliquots of the soluble extract from microsomes (lane 1), of the
pooled fractions after chromatography on MonoQ (lane 2), conca-
navalin A-Sepharose (lane 3), and scrambled peptide-Affigel 10 (lane
4) were separated by SDS-PAGE. The entire material eluted from
Ser-69 peptide-Affigel 10 was concentrated and loaded in lane 5.
Molecular weight standards are shown at the right. Proteins wereFigure 1. FGly Modification of P23
stained with SYPRO Ruby. The numbers below lanes 1–5 refer to6 pmol of P23 were incubated under standard conditions for 10 min
the percentage of the material loaded onto the gel.at 37C in the absence (top) or presence (bottom) of 1 l microsomal
extract. The samples were prepared for MALDI-TOF mass spec-
trometry as described in Experimental Procedures. The monoiso-
topic masses MH of P23 (2526.28) and its FGly derivative (2508.29) (scrambled peptide PVSLPTRSCAALLTGR). This pep-
are indicated. tide did not inhibit FGE activity when added at 10 M
concentration to the in vitro assay and, when immobi-
lized to Affigel 10, did not retain FGE activity. Chroma-
creas or bovine testis converted up to 95% of the pep- tography on the scrambled peptide affinity matrix re-
tide into the FGly containing derivative (Figure 1). Under moved peptide binding proteins including chaperones
standard conditions, the FGly formation was propor- of the endoplasmic reticulum. The second affinity matrix
tional to the amount of enzyme and time of incubation was Affigel 10 substituted with a variant of the ASA65–80
as long as less than 50% of the substrate was consumed peptide, in which the Cys-69 was replaced by a serine
and the incubation period did not exceed 24 hr. The KM (Ser-69 peptide PVSLSTPSRAALLTGR). The Ser-69
for P23 was 13 nM. The effects of reduced and oxidized peptide affinity matrix efficiently bound FGE. The FGE
glutathione, Ca2, and pH were comparable to those activity could be eluted with 20%–40% recovery with
seen in the assay using ribosome-associated nascent either 2 M KSCN or 25 M Ser-69 peptide. Prior to
chain complexes as substrate (Fey et al., 2001). activity determination, the KSCN or Ser-69 peptide had
to be removed by dialysis. The substitution of Cys-69
by serine was crucial for the elution of active FGE. AffigelPurification of FGE
10 substituted with the wild-type ASA65–80 peptideFor purification of FGE, the soluble fraction (reticu-
bound FGE efficiently. However, nearly no activity couldloplasm) of bovine testis microsomes served as the
be recovered in eluates with chaotropic salts (KSCN,starting material. The specific activity of FGE was 10–20
MgCl2), peptides (ASA65–80, or Ser-69 peptide), or buff-times higher than that in reticuloplasm from bovine pan-
ers with low or high pH.creas microsomes (Fey et al., 2001). Purification of FGE
In Figure 2 the polypeptide pattern of the startingwas achieved by a four-step chromatography. The first
material and of the active fractions obtained after thetwo steps were chromatography on a MonoQ anion ex-
four chromatographic steps of a typical purification ischanger and on concanavalin A-Sepharose. At pH 8, the
shown. In the final fraction, 5% of the starting FGE activ-FGE activity bound to MonoQ and was eluted at 50–165
ity and 0.0006% of the starting protein were recoveredmM NaCl with 60%–90% recovery. When this fraction
(8333-fold purification).was mixed with concanavalin A-Sepharose, FGE was
bound. 30%–40% of the starting activity could be eluted
with 0.5 M -methyl mannoside. The two final purifica- The Purified 39.5 and 41.5 kDa Polypeptides
Are Encoded by a Single Genetion steps were chromatography on affinity matrices
derivatized with 16-mer peptides. The first affinity matrix The 39.5 and 41.5 kDa polypeptides in the final FGE
preparation (see Figure 2, lane 5) were subjected towas Affigel 10 substituted with a variant of the ASA65–80
peptide, in which the three residues critical for FGly peptide mass fingerprint analysis. The mass spectra of
the tryptic peptides of the two polypeptides obtainedformation, Cys-69, Pro-71, and Arg-73, were scrambled
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Figure 3. Amino Acid Sequence of Human
FGE
The sequence is deduced from the cloned
cDNA. The sequence deviates from that en-
coded by the human cDNA AK075459 at resi-
due 124, F instead of L, and at residue 264,
E instead of D. The two peptides identified in
bovine FGE are underlined by a stippled bar.
The predicted cleavage site for the signal
peptidase at Gly-33 is indicated by an arrow
head and the N-glycosylation site at Asn-141
by an asterisk. Subdomain one (light gray),
subdomain two (gray), and subdomain three
(dark gray) are underlined by filled bars.
by MALDI-TOF mass spectrometry were largely overlap- that this domain is composed of three distinct subdo-
mains.ping, suggesting that the two proteins originate from
the same gene. Among the tryptic peptides of both poly- The N-terminal subdomain (residues 91–154 in human
FGE) has a sequence identity of 39% and a similarity ofpeptides, two abundant peptides (MH 1580.73,
SQNTPDSSASNLGFR, and MH 2049.91, MVPIPAGVF 85% within the six known full-length eukaryotic FGE
orthologs. In human FGE, this domain carries theTMGTDDPQIK with the two methionine residues oxi-
dized) were found, which matched to the protein en- N-glycosylation site at Asn-141, which is conserved in
the other orthologs. The middle part of FGE (residuescoded by the human cDNA AK075459. The amino acid
sequence of the two peptides was confirmed by MALDI- 179–308 in human FGE) is represented by a tryptophan-
rich subdomain (12 tryptophans per 129 residues). TheTOF post source decay spectra and by MS/MS analysis
using offline nano-electrospray ionisation (ESI) iontrap identity of the eukaryotic orthologs within this subdo-
main is 48%, the similarity 72%. The C-terminal subdo-mass spectrometry. An EST sequence of the bovine
ortholog covering the C-terminal part of FGE and match- main (residues 327–366 in human FGE) is the most highly
conserved sequence within the FGE family. The se-ing the sequence of the MH 1580.73 peptide provided
additional sequence information for bovine FGE. quence identity of the human C-terminal subdomain with
the eukaryotic orthologs is 85%, the similarity 100%.
Within the 40 residues of the subdomain three, fourEvolutionary Conservation and Domain
Structure of FGE cysteine residues are fully conserved. Three of these
cysteines are also conserved in the prokaryotic FGEThe gene encoding human FGE, designated as SUMF1
(sulfatase modifying factor 1) is located on chromosome orthologs.
In vertebrates (man, mouse, rat, and fugu), a paralog of3p26. It spans 105 kb and the coding sequence is distrib-
uted over 9 exons. Orthologous genes are found in the SUMF1 gene exists, which is designated as SUMF2
gene. SUMF2 originating EST sequences are docu-mouse (87% identity), rat (94% identity), Drosophila me-
lanogaster (48% identity), Anopheles gambiae (47% mented for eight additional vertebrate species. Among
the SUMF2 encoded proteins, the identity is muchidentity), and Fugu rubripes (63% identity). Orthologous
EST sequences are found for a number of further species higher than to the SUMF1 encoded FGE of the same
species. For example, the identity between the humanincluding cow, pig, chicken, Xenopus laevis, Silurana
tropicalis, zebra fish, other fish species, and sea urchin and mouse SUMF2 encoded protein is 86%, while the
identity with the corresponding FGE is 47%–49%. The(for details see J. Landgrebe, T.D., B.S., and K.v.F., un-
published data). The exon-intron structure between the SUMF2 encoded proteins share with FGE the subdo-
main structure. In subdomain three, however, they lackhuman and the mouse gene is conserved, and the mouse
gene on chromosome 6E2 is located within a region two of the three cysteines conserved among pro- and
eukaryotic FGEs.syntenic to the human chromosome 3p26. The genomes
of S. cerevisiae and C. elegans lack SUMF1 homologs.
In prokaryotes, 13 orthologs of the SUMF1 gene were Expression and Subcellular Localization of FGE
A single transcript of 2.1 kb is detectable by Northernfound.
The cDNA for human FGE is predicted to encode a blot analysis of total RNA from skin fibroblasts (data not
shown) and poly A RNA from heart, brain, placenta,protein of 374 residues (Figure 3). The protein contains
a cleavable signal sequence of 33 residues, which indi- lung, liver, skeletal muscle, kidney, and pancreas (Figure
4A). Relative to -actin RNA, the abundance varies bycates translocation of FGE into the endoplasmic reticu-
lum, and contains a single N-glycosylation site at Asn- one order of magnitude and is highest in pancreas and
kidney and lowest in brain. Various eukaryotic cell lines141. The binding of FGE to concanavalin A suggests
that this N-glycosylation site is utilized. Residues 87–367 stably or transiently expressing the cDNA of human FGE
or FGE derivatives C-terminally extended by an HA-,of FGE are listed in the PFAM protein motif database
as a domain of unknown function (PFAM: DUF323). Se- Myc-, or His6-tag were assayed for FGE activity and
subcellular localization of FGE. Transient expression ofquence comparison analysis of human FGE and its
eukaryotic orthologs identified in databases indicates tagged and non-tagged FGE increased the FGE activity
Cell
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Figure 4. Expression, Molecular Forms, and Subcellular Localization of FGE and C-Terminally Tagged FGE
(A) Northern blot analysis of polyA RNA from human tissues for FGE (top) and -actin (bottom).
(B) FGE activity of cells transiently or stably expressing FGE and C-terminally tagged FGE versions. BHK 21 cells (black bars) were transfected
with pMPSV vectors containing the cDNA for human FGE or FGE C-terminally tagged with the His6-, HA-, or Myc-tag. Cells were harvested
2 days after transfection. PT67 cells (open bars) were transduced with pLPCX or pLPCX-FGE and selected with puromycin. The range or
variation of two to nine independent determinations is indicated.
(C) Western blot analysis of BHK 21 cells transiently transfected with cDNAs encoding FGE or FGE with a C-terminal Myc-, HA-, or His6-tag.
Cell extracts were separated by SDS-PAGE, transferred onto PVDF membrane, and probed with monoclonal antibodies against the Myc-,
HA-, or His6-epitope.
(D) Subcellular localization of FGE-HA in HT-1080 cells. After fixation and permeabilization, the HA-tag (red) and proteindisulfide isomerase
(green) were detected with monoclonal antibodies. In cells expressing FGE-HA, the FGE-HA colocalizes with proteindisulfide isomerase
(yellow).
1.6- to 3.9-fold (Figure 4B). Stable expression of FGE in that were confirmed by sequencing the genomic DNA
(Table 1). The first patient was heterozygous for aPT67 cells increased the activity of FGE about 100-fold
(Figure 4B). 1076CA substitution, converting the codon for serine
359 into a stop codon (S359X) and a mutation causingIndirect immunofluorescence showed the colocaliza-
tion of the variously tagged forms of FGE with proteindi- the deletion of the 25 residues 149–173 that are encoded
by exon 3 and space the first and the second domainsulfide isomerase, a lumenal protein of the endoplasmic
reticulum in BHK21, CHO and HT1080 cells (shown in of the protein. Genomic sequencing revealed a deletion
of nucleotides 5–8 of the third intron (IVS35-8 del),Figure 4D for HA-tagged FGE in HT 1080 cells). Western
blot analysis of extracts from BHK 21 cells transiently thereby destroying the splice donor site of intron 3. The
second patient was heterozygous for the mutation caus-transfected with cDNA encoding tagged forms of FGE
showed a single immunoreactive band with an apparent ing the loss of exon 3 (IVS35-8 del) and a 979CT
substitution, converting the codon for arginine 327 intosize between 42 to 44 kDa (Figure 4C).
a stop codon (R327X). The truncated FGE encoded by
the 979CT allele lacks most of subdomain three. TheThe FGE Encoding SUMF1 Gene Carries
Mutations in MSD third patient was homozygous for a 1045CT substitu-
tion, replacing the conserved arginine 349 in subdomainMSD is caused by a deficiency to generate FGly residues
in sulfatases (Schmidt et al., 1995). The FGE encoding three by tryptophan (R349W). The fourth patient was
heterozygous for two missense mutations replacingSUMF1 gene is therefore a candidate gene for MSD. We
amplified and sequenced the FGE encoding cDNA of conserved residues in subdomain three: a 1046GA
substitution replacing arginine 349 by glutamineseven MSD patients and found nine different mutations
Molecular Defect in Multiple Sulfatase Deficiency
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Table 1. Mutations in MSD Patients
Mutation Effect on Protein Remarks Patient
1076CA S359X truncation of the C-terminal 16 residues one
IVS35-8 del deletion of residues 149–173 in-frame deletion of exon 3 one, two
979CT R327X loss of subdomain three two
1045CT R349W substitution of a conserved residue in subdomain three three, seven
1046GA R349Q substitution of a conserved residue in subdomain three four
1006TC C336R substitution of a conserved residue in subdomain three four
836CT A279V substitution of a conserved residue in subdomain two five
243delC frameshift and truncation loss of all three subdomains five
661delG frameshift and truncation loss of the C-terminal third of FGE, including subdomain three six
Patient one is the MSD patient Mo. in Schmidt et al. (1995) and Rommerskirch and von Figura (1992). Patient six is the MSD patient reported
by Burch et al. (1986). The other patients represent unpublished cases.
(R349Q) and a 1006TC substitution replacing cysteine Discussion
336 by arginine (C336R). The fifth patient was heterozy-
FGE Is a Highly Conserved Glycoproteingous for an 836 CT substitution, replacing the con-
of the Endoplasmic Reticulumserved alanine 279 by valine (A279V). The second mu-
Purification of FGE from bovine testis yielded two poly-tation was a single nucleotide deletion (243delC),
peptides of 39.5 and 41.5 kDa that originate from thechanging the sequence after proline 81 and causing a
same gene. We cannot formally exclude that FGE existstranslation stop after residue 139. The sixth patient was
in testis in two forms, e.g., due to a limited proteolysis,heterozygous for the deletion of a single nucleotide
distinct N-glycosylation, tight binding of a cofactor, or(661delG), changing the amino acid sequence after resi-
the existence of alternate transcripts. The expressiondue 220 and introducing a stop codon after residue
of three differently tagged versions of FGE, each in three266. The second mutation remains to be identified. The
different eukaryotic cell lines, as a single form, however,seventh patient was homozygous for the same 1045CT
renders it likely that the smaller of the two forms ob-substitution found in the third patient. In addition, we
served in the FGE preparation purified from bovine testisdetected two polymorphisms in the coding region of 22
has been generated by limited proteolysis during purifi-SUMF1 alleles from controls and MSD patients. 36%
cation.carried a 188GA substitution, replacing serine 63 by
The substitution of Cys-69 in the ASA65–80 peptide byasparagine (S63N) and 32% a silent 1116CT substi-
serine was critical for the purification of FGE by affinitytution.
chromatography. Preliminary experiments had shown
that both the Ser-69 peptide and the Cys-69 containing
Transduction of MSD Fibroblasts with cDNAs ASA65–80 peptide inhibit FGly formation in an in vitro
Encoding Wild-Type and Mutant FGE assay with comparable efficiency. Yet active FGE was
In order to confirm the deficiency of FGE as the cause only recovered from the affinity matrix substituted with
of the inactivity of sulfatases synthesized in MSD, we the Ser-69 peptide. The latter cannot be modified by
expressed the FGE encoding cDNA in MSD fibroblasts FGE. For yet unknown reasons, active FGE was not
utilizing retroviral gene transfer. As a control, we trans- recovered after incubation with an affinity matrix substi-
duced the retroviral vector without cDNA insert. To mon- tuted with ASA65-80 peptide, which is a substrate of
itor the complementation of the metabolic defect the FGE.
activity of ASA, steroid sulfatase (STS) and N-acetylga- FGE has a cleavable signal sequence that mediates
lactosamine 6-sulfatase (GalNAc6S) were measured in translocation across the membrane of the endoplasmic
the transduced fibroblasts prior or after selection. Trans- reticulum. The greater part of the mature protein (275
duction of the cDNA encoding wild-type FGE partially residues out of 340) defines a unique domain, which is
restored the catalytic activity of the three sulfatases in likely to be composed of three subdomains (for details
two MSD-cell lines (Table 2) and for STS in a third MSD see J. Landgrebe, T.D., B.S. and K.v.F., unpublished
cell line (data not shown). Selection of transduced fibro- data). None of the functions to be fulfilled by FGE, such
blasts increased the activity of ASA and STS 2- to 5-fold, as the recognition of the FGly modification motif in newly
which agrees with the earlier observation that 15%–50% synthesized sulfatase polypeptides (Dierks et al., 1999)
of human diploid fibroblasts are transduced by this pro- or the catalysis of the cysteine to FGly conversion can
cedure (Lu¨bke et al., 2001). It may be noted that the be assigned to one of the subdomains as for none of
activity of STS reached normal level after selection, them homologs exist in proteins with known function.
while in the same cultures that of ASA and GalNAc6S The catalytic domain in FGE could catalyze the FGly
reached only 20%–50% of control. The sulfatase activi- formation in several ways. It has been proposed that
ties in the MSD fibroblasts transduced with the retroviral FGE abstracts electrons from the thiol group of the cys-
vector alone (Table 2) were comparable to those in non- teine and transfers them to an acceptor. The resulting
transduced MSD fibroblasts (data not shown). Trans- thioaldehyde would spontaneously hydrolyze to FGly
duction of FGE encoding cDNA derived from a MSD and H2S (Schmidt et al., 1995). Alternatively, FGE could
patient carrying the IVS35-8del mutation failed to re- act as a mixed-function oxygenase (monooxygenase)
introducing one atom of O2 into the cysteine and thestore the sulfatase activities (Table 2).
Cell
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Table 2. Complementation of MSD fibroblasts by Transduction of cDNA Encoding Wild-Type or Mutant FGE
Sulfatase Activity
Fibroblasts FGE Encoding cDNA ASAa STSa GalNAc6Sa
MSD 3b – 1.9  0.2 3 56.7  32
FGEc 7.9 13.5 n.d.
FGEd 12.2  0.2 75.2 283  42
FGE-IVS35-8delc 1.8 3 n.d.
FGE-IVS35-8deld 2.1 3 98.5
MSD 4b – 1.1  0.3 3 n.d.
FGEc 4.7 17.0 n.d.
Control fibroblasts 58  11 66  31 828  426
a The values give the ratio between the sulfatases, ASA (mU/mg cell protein), STS (U/mg cell protein), GalNAc6S (U/mg cell protein) and
that of the lysosomal reference enzyme ß-hexosaminidase (U/mg cell protein). For control fibroblasts the mean and the variation of 6-11 cell
lines is given. Where indicated the range of two cultures transduced in parallel is given for MSD fibroblasts.
b The MSD fibroblast number refers to that of the patients in Table 1.
c Activity determination prior to selection.
d Activity determination after selection.
Abbreviations: n.d., not determined.
other into H2O with the help of an electron donor such are needed for enzyme replacement therapy of patients
suffering from the deficiency of a lysosomal sulfatase,as FADH2. The resulting thioaldehyde hydrate derivative
would spontaneously react to FGly and H2S. Preliminary e.g., of arylsulfatase B in Maroteaux-Lamy disease, idur-
onate sulfatase in Hunter disease, and galactose 6-/N-experiments with a partially purified FGE preparation
show a critical dependence of the FGly formation on acetylgalactosamine 6-sulfatase in Morquio A disease
(for review see Neufeld and Muenzer, 2001).molecular oxygen. This would suggest that FGE acts as
a mixed-function oxygenase. The particular high conser-
vation of subdomain three and the presence of three in Mutations in SUMF1 Cause MSD
It was the biochemical phenotype of MSD that providedall orthologs conserved cysteine residues therein make
this subdomain a likely candidate for the catalytic site. It the first hint to a unique posttranslational modification
in sulfatases required for their activity. This modificationwill be of interest to see whether the structural elements
mediating the recognition of the FGly motif and the bind- was shown to be the conversion of cysteine to FGly and
to be missing in sulfatases from MSD patients (Schmidting of an electron acceptor or electron donor correlate
with the domain structure of FGE. et al., 1995). The gene encoding FGE was therefore a
strong, but not obligatory, candidate for the site of muta-Recombinant FGE is localized in the endoplasmic re-
ticulum. This agrees with the proposed site of its action. tions in MSD. FGE may interact with other components
and defects in genes encoding the latter could equallyFGly residues are generated in newly synthesized sul-
fatases during or shortly after their translocation into well cause MSD. In seven MSD patients, we indeed
found nine different mutations in SUMF1, the gene en-the endoplasmic reticulum (Dierks et al., 1997, 1998a).
FGE itself does not contain an ER-retention signal of coding FGE. All mutations have severe effects on the
FGE protein by either replacing highly conserved resi-the KDEL type. Its retention in the endoplasmic reticu-
lum may therefore be mediated by the interaction with dues in subdomain three (three mutations) or subdomain
two (one mutation), or by causing C-terminal truncationsother ER proteins. Components of the translocation/
N-glycosylation machinery are attractive candidates for of various lengths (four mutations) or large in-frame dele-
tions (one mutation). For three MSD-cell lines, it wassuch interacting partners.
shown that transduction of the FGE encoding cDNA
partially or fully restores the sulfatase activities. On theFGE as a Tool to Improve the Production
of Recombinant Sulfatases contrary, transduction with a FGE encoding cDNA car-
rying one of the mutations observed in MSD patientsOverexpression of sulfatases can be associated with a
decrease of the activity of endogenous sulfatases (An- did not restore the sulfatase activities. This clearly iden-
tifies the SUMF1 gene as the site of the disease-causingson et al., 1993). Furthermore, only a fraction of the
recombinant sulfatases is active. This has been ascribed mutations. Using an alternative genetic approach based
on the restoration of sulfatase activities by microcell-to the saturation of the mechanism posttranslationally
generating the FGly residues in the active site of sul- mediated chromosome transfer, M.P. Cosma et al. (2003
[this issue of Cell]) also identified the FGE encodingfatases. In accordance with that, a fraction of the re-
combinant sulfatases retains the unmodified cysteine SUMF1 gene as the gene carrying the mutations causing
MSD.(Schmidt et al., 1995). Coexpression of FGE and sul-
fatases may therefore be a means to increase the yield MSD is both clinically and biochemically heteroge-
nous. A rare neonatal form presenting at birth and devel-of catalytically active sulfatases. In fact, coexpression
of FGE and galactose 6-sulfatase in eukaryotic cells oping a hydrocephalus (Vamos et al., 1981; Burch et al.,
1986), a common form resembling initially an infantilewas found to increase the specific activity of galactose
6-sulfatase about 50-fold (M. Heartlein, personal com- metachromatic leukodystrophy and subsequently de-
veloping ichthyosis- and mucopolysaccharidosis-likemunication). Catalytically active recombinant sulfatases
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features (Austin, 1973; Rampini et al., 1970; Couchot et FGE supporting activity of the SUMF2 encoded proteins
are preliminary experiments in which the activity of aryl-al., 1974), and a less-frequent mild form in which the
clinical features of a mucopolysaccharidosis prevail sulfatase A increased when its cDNA was coexpressed
with the SUMF2 cDNA.(Burk et al., 1984) have been differentiated. Biochemi-
cally it is characteristic that a residual activity of sul-
Experimental Proceduresfatases is detected, which in cultured skin fibroblasts
generally is below 10% of controls (Burch et al., 1986;
In Vitro Assay for FGE
Basner et al., 1979). However, in some MSD cell lines For monitoring the activity of FGE, the N-acetylated and C-amidated
the activity of selected sulfatases can reach the normal 23-mer peptide P23 (MTDFYVPVSLCTPSRAALLTGRS) was used as
substrate. The conversion of the cysteine residue in position 11 torange (Yutaka et al., 1981). Furthermore, the residual
FGly was monitored by MALDI-TOF mass spectrometry. A 6 Mactivity is subject to variations, depending on the cell
stock solution of P23 in 30% acetonitrile and 0.1% trifluoroaceticculture conditions and unknown factors (Fluharty et al.,
acid (TFA) was prepared. Under standard conditions, 6 pmol P231978, 1979; Kresse and Holtfrerich, 1980; Chang et al.,
were incubated at 37C with up to 10 l enzyme in a final volume
1983). Biochemically, MSD has been classified into two of 30 l 50 mM Tris/HCl (pH 9.0), containing 67 mM NaCl, 15 M
groups (Chang et al., 1983; Steckel et al., 1985; Conary CaCl2, 2 mM DTT, and 0.33 mg/ml bovine serum albumin. To stop
the enzyme reaction, 1.5 l 10% TFA was added. P23 then waset al., 1988). In group I, the residual activity of sulfatases
bound to ZipTip C18 (Millipore), washed with 0.1% TFA, and elutedis below 15%, including that of ASB. In group II, the
in 3 l 50% acetonitrile, 0.1% TFA. 0.5 l of the eluate was mixedresidual activity of sulfatases is higher and particularly
with 0.5 l of matrix solution (5 mg/ml -cyano-4-hydroxy-cinnamicthat of ASB may reach values of up to 50%–100% of
acid (Bruker Daltonics) in 50% acetonitrile, 0.1% TFA) on a stainless
control. All patients reported here fall into group I except steel target. MALDI-TOF mass spectrometry was done with a Reflex
patient 5, who falls into group II (ASB activity in the III (Bruker Daltonics) using reflectron mode and laser energy just
above the desorption/ionization threshold. All spectra were aver-control range) of the biochemical phenotype. Based on
ages of 200–300 shots from several spots on the target. The massclinical criteria, patients 1 and 6 are neonatal cases,
axis was calibrated using peptides of molecular masses rangingwhile patients 2–5 and 7 have the common form of MSD.
from 1000–3000 Da as external standards. Monoisotopic MH ofThe 1045CT substitution was the only homozygous
P23 is 2526.28 and of the FGly containing product 2508.29. Activity
mutation in MSD patients. Both patient 3 and 7 are of (pmol product/hr) was calculated on the basis of the peak height
Turkish origin, suggesting that the 1045CT substitu- of the product divided by the sum of the peak heights of P23 and
the product.tion might be more frequent in Turkey.
The phenotypic heterogeneity suggests that the dif-
Purification of FGE from Bovine Testisferent mutations in MSD patients are associated with
Bovine testes were obtained from the local slaughterhouse anddifferent residual activities of FGE. Preliminary data on
stored for up to 20 hr on ice. The parenchyme was freed from
PT67 cells stably expressing the FGE mutant with the connective tissue and homogenized in a waring blendor and by
in-frame deletion of exon 3 indicate that this mutation three rounds of motor pottering. Preparation of rough microsomes
(RM) by cell fractionation of the obtained homogenate was per-abolishes FGE activity completely. The characterization
formed as described (Meyer et al., 2000) with the following modifica-of the mutations in MSD, of the biochemical properties
tions. Three differential centrifugation steps, 20 min each at 4C,of the mutant FGE, and of the residual content of FGly
were performed at 500 	 g (JA10 rotor), 3000 	 g (JA10), andin sulfatases using a recently developed highly sensitive
10000 	 g (JA20). From the last supernatant the RM membranes
mass spectrometric method (Peng et al., 2003) will pro- were sedimented (125,000 	 g, Ti45 rotor, 45 min, 4C), homoge-
vide a better understanding of the genotype-phenotype nized by motor pottering, and layered on a sucrose cushion (50 mM
Hepes [pH 7.6], 50 mM KAc, 6 mM MgAc2, 1 mM EDTA, 1.3 Mcorrelation in MSD.
sucrose, and 5 mM -mercaptoethanol). RMs were recovered from
the pellet after spinning for 210 min at 45,000 rpm in a Ti45 rotor atIs There a Second FGE Encoding Gene
4C. Usually 100,000–150,000 equivalents RM, as defined by Walter
in Man and Mouse? and Blobel (1983), were obtained from 1 kg of testis tissue. The
The SUMF2 genes in vertebrates are predicted to en- reticuloplasm, i.e., the luminal content of the RM, was obtained by
differential extraction at low concentrations of deoxy Big Chap, ascode proteins with a substantial overall homology to the
described (Fey et al., 2001).SUMF1 encoded FGE. The homology extends over all
For FGE purification, 95 ml of reticuloplasm were dialyzed for 20three subdomains. This raises the possibility that the
hr at 4C against 20 mM Tris/HCl (pH 8.0) and 2.5 mM DTT, andSUMF2 encoded proteins have FGly-generating activity.
cleared by centrifugation at 125,000 	 g for 1 hr. 32 ml aliquots of
As discussed above, many studies have revealed minor the cleared reticuloplasm were loaded on a MonoQ HR10/10 column
residual sulfatase activities in MSD fibroblasts (Burch (Amersham Biosciences) at room temperature, and washed and
eluted at 2 ml/min with a linear gradient of 0 to 0.75 M NaCl in 80et al., 1986; Basner et al., 1979). Even in the most severe
ml of the Tris buffer. The fractions containing FGE activity, elutingform of MSD with neonatal onset residual sulfatase ac-
at 50–165 mM NaCl, of three runs were pooled (42 ml) and mixedtivities were found and the level of residual activity was
with 2 ml of concanavalin A-Sepharose (Amersham Biosciences)cell type dependent, being higher in leukocytes than in
that had been washed with 50 mM Hepes buffer (pH 7.4), containing
fibroblasts (Burch et al., 1986). The residual sulfatase 0.5 M KCl, 1 mM MgCl2, 1 mM MnCl2, 1 mM CaCl2, and 2.5 mM DTT.
activity in MSD may reflect a residual activity of the After incubation for 16 hr at 4C, the concanavalin A-Sepharose was
collected in a column and washed with 6 ml of the same Hepesmutant forms of FGE. However, in patients with severe
buffer. The bound material was eluted by incubating the column formutations, such as large deletions, the residual activity
1 hr at room temperature with 6 ml 0.5 M -methylmannoside in 50of sulfatases may well arise from a FGE activity of the
mM Hepes (pH 7.4) and 2.5 mM DTT. The elution was repeatedSUMF2 encoded protein. In fact, a minor FGE activity
with 4 ml of the same eluent. The combined eluates (10 ml) from
of the SUMF2 encoded protein may be essential for concanavalin A-Sepharose were adjusted to pH 8.0 with 0.5 M Tris/
the development till birth and the short postnatal life HCl (pH 9.0) and mixed with 2 ml of Affigel 10 (BioRad) that had
been derivatized with 10 mg of the scrambled peptideobserved for the neonatal form of MSD. In line with a
Cell
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(PVSLPTRSCAALLTGR) and washed with buffer A (50 mM Hepes Cell Lines and Cell Culture
The fibroblasts from MSD patients 1–7 were obtained from E. Chris-[pH 8.0], containing 0.15 M potassium acetate, 0.125 M sucrose, 1
mM MgCl2, and 2.5 mM DTT). After incubation for 3 hr at 4C the tenson (1, Rigshospitalet Copenhagen), M. Beck (2, Universita¨t-
skinderklinik Mainz), A. Kohlschu¨tter (3, Universita¨tskrankenhausaffinity matrix was collected in a column. The flow through and a
wash fraction with 4 ml of buffer A were collected, combined, and Eppendorf, Hamburg), E. Zammarchi (4, Meyer Hospital, University
of Florence), K. Harzer (5 and 7, Institut fu¨r Hirnforschung, Universita¨tmixed with 2 ml of Affigel 10 that had been substituted with 10
mg of the Ser-69 peptide (PVSLSTPSRAALLTGR) and washed with Tu¨bingen), and A. Fensom (6, Guy’s Hospital, London), respectively.
Human skin fibroblasts, HT-1080, BHK21, and CHO cells were main-buffer A. After incubation overnight at 4C, the affinity matrix was
collected in a column, washed three times with 6 ml of buffer B tained at 37C under 5% CO2 in Dulbecco’s modified Eagle’s medium
containing 10% fetal calf serum.(buffer A containing 2 M NaCl and a mixture of the 20 proteinogenic
amino acids, each at 50 g/ml). The bound material was eluted from
the affinity matrix by incubating the Affigel twice for 90 min each Transfection, Indirect Immunofluorescence, Western Blot
with 6 ml buffer B containing 25 M Ser-69 peptide. An aliqout of Analysis, and Detection of FGE Activity
the eluate was substituted with 1 mg/ml bovine serum albumin, The FGE encoding cDNA was equipped with a 5
 EcoRI site and
dialyzed against buffer A, and analyzed for activity. The remaining either a 3
 HA-, c-Myc, or RGS-His6-tag sequence, followed by a
part of the activity (11.8 ml) was concentrated in a Vivaspin 500 stop-codon and a HindIII site, by add-on PCR using Pfu polymerase
concentrator (Vivascience) and solubilized at 95C in Laemmli SDS (Stratagene) and the following primers: GGAATTCGGGACAACAT
sample buffer. The polypeptide composition of the starting material GGCTGCG (EcoRI), CCCAAGCTTATGCGTAGTCAGGCACATCATA
and preparations obtained after the chromatographic steps were CGGATAGTCCATGGTGGGCAGGC (HA), CCCAAGCTTACAGGTCT
monitored by SDS-PAGE (15% acrylamide and 0.16% bisacrylam- TCTTCAGAAATCAGCTTTTGTTCGTCCATGGTGGGCAGGC (c-Myc),
ide) and staining with SYPRO Ruby (BioRad). and CCCAAGCTTAGTGATGGTGATGGTGATGCGATCCTCTGTCCA
TGGTGGGCAGGC (RGS-His6). The resulting PCR products were
cloned as EcoRI/HindIII fragments into pMPSVEH (Artelt et al., 1988).
Identification of FGE by Mass Spectrometry
The plasmids obtained were transiently transfected into HT-1080,
For peptide mass fingerprint analysis, the purified polypeptides were
BHK21, and CHO cells and grown on cover slips, using Effectene
in-gel digested with trypsin (Shevchenko et al., 1996), desalted on
(Qiagen) as transfection reagent. 48 hr after transfection, the cells
C18 ZipTip, and analyzed by MALDI-TOF mass spectrometry using
were analyzed by indirect immunofluorescence as described pre-
dihydrobenzoic acid as matrix and two autolytic peptides from tryp-
viously (Lu¨bke et al., 2001; Hansske et al., 2002.), using monoclonal
sin (m/z 842.51 and 2211.10) as internal standards. For tandem mass
IgG1 antibodies against HA (BAbCO, Richmond), c-Myc (Santa Cruz),spectrometry analysis selected peptides were analyzed by MALDI-
or RGS-His (Qiagen) as primary antibodies. The endoplasmic reticu-
TOF post source decay mass spectrometry. Their corresponding
lum marker protein proteindisulfide isomerase (PDI) was detected
doubly charged ions were isolated and fragmented by offline nano-
with a monoclonal antibody of different subtype (IgG2A, Stressgen).ESI ion trap mass spectrometry (EsquireLC, Bruker Daltonics). The
The primary antibodies were detected with isotype-specific goat
mass spectrometric data were used by Mascot search algorithm
secondary antibodies coupled to CY2 or CY3, respectively (Molecu-
for protein identification in the NCBInr protein database and the
lar Probes). Immunofluorescence images were obtained on a Leica
NCBI EST nucleotide database.
TCS Sp2 AOBS laser scan microscope. For Western blot analysis,
the same monoclonal antibodies and a HRP-conjugated anti-mouse
IgG as secondary antibody were used.Bioinformatics
For determination of FGE activity, the trypsinized cells wereSignal peptides and clevage sites were described with the method
washed with phosphate-buffered saline containing a mixture of pro-of von Heijne (1986) implemented in EMBOSS (Rice et al., 2000).
teinase inhibitors (208 M 4-(2-aminoethyl)benzene sulfonyl fluorideN-glycosylation sites were predicted using the algorithm of Brunak
hydrochloride, 0.16M aprotinin, 4.2M leupeptin, 7.2M bestatin,(Gupta and Brunak, 2002). Functional domains were detected by
3 M pepstatin A, 2.8 M E-64); solubilized in 10 mM Tris (pH 8.0),searching PFAM-Hidden-Markov-Models (version 7.8) (Sonnham-
containing 2.5 mM DTT, the proteinase inhibitors, and 1% Tritonmer et al., 1998). To search for FGE homologs, the databases of
X-100; and cleared by centrifugation at 125,000 	 g for 1 hr. Thethe National Center for Biotechnology Information (Wheeler et al.,
supernatant was subjected to chromatography on a MonoQ PC2002) were queried with BLAST (Altschul et al., 1997). Sequence
1.6/5 column using a 1 ml gradient of 0 to 375 mM NaCl in the Trissimilarities were computed using standard tools from EMBOSS.
buffer described above and a flow rate of 0.1 ml/min. FractionsGenomic loci organization and synteny were determined using the
eluting at 50–200 mM NaCl were pooled, lyophilized, and reconstitu-NCBI’s human and mouse genome resources (http://www.ncbi.
ted in one-tenth of the original pool volume prior to determinationnlm.nih.gov/genome/guide/) and the human-mouse homology map
of FGE activity with peptide P23.(http://www.ncbi.nlm.nih.gov/Homology/).
Retroviral Transduction
Cloning of Human FGE Encoding cDNA cDNAs of interest were cloned into the Moloney murine leukemia
Total RNA, prepared from human fibroblasts using the RNeasy Mini virus based vector pLPCX and pLNCX2 (Clontech). The transfection
kit (Qiagen) was reverse transcribed using the Omniscript RT kit of ecotropic φNX-Eco cells (ATCC) and the transduction of ampho-
(Qiagen) and either an oligo(dT) primer or the SUMF1-specific primer tropic RetroPack PT67 cells (Clontech) and human fibroblasts were
1199nc (CCAATGTAGGTCAGACACG). The first strand cDNA was done as described (Lu¨bke et al., 2001; Thiel et al., 2002.). For some
amplified by PCR using the forward primer 1c (ACATGGCCCGCGG experiments, pLPCX-transduced PT67 cells were selected with pu-
GAC) and, as reverse primer, either 1199nc or 1182nc (CGACTGCT romycin prior determination of sulfatase activities.
CCTTGGACTGG). The PCR products were cloned directly into the
pCR4-TOPO vector (Invitrogen). By sequencing multiples of the
Sulfatase Assays
cloned PCR products, which had been obtained from various indi-
Activity of ASA, STS, and GalNAc6S were determined as described
viduals and from independent RT and PCR reactions, the coding
(Rommerskirch and von Figura, 1992; Glo¨ssl and Kresse, 1978).
sequence of the SUMF1 cDNA (1125 bp from start to stop codon)
was established.
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Accession Numbers
The GenBank accession number for the SUMF1 sequence reported
in this paper is AY 208752. The detected SNP polymorphisms were
also deposited under this accession number.
